Moderna just got FDA approval for its RSV vaccine — only its second product on the market
@dailywire.com3 years ago
FDA Approves Second Booster For Older Adults, Some Immunocompromised People
@WSJ3 years ago
Pfizer asked the FDA to authorize a second booster dose of its Covid-19 vaccine for people 65 years and older. Regulators are expected to decide in time for the Biden administration to begin a potential fall vaccine campaign. on.wsj.com
